about
Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic painGabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neuronesDiabetes mellitus and its chronic complications.A comparison of Ca2+ channel blocking mode between gabapentin and verapamil: implication for protection against hypoxic injury in rat cerebrocortical slices.A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injuryDetermination of Gabapentin in Human Plasma and Urine by Capillary Electrophoresis with Laser-Induced Fluorescence Detection.The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.Spinal and supraspinal contributions to central sensitization in peripheral neuropathy.Neuropathic pain: are we out of the woods yet?Painful limbs/moving extremities.Targeting voltage-gated calcium channels for neuropathic pain management.Steady-state pharmacokinetics of gabapentin after administration of a novel gastroretentive extended-release formulation in postmenopausal women with vasomotor symptoms.Comparison of the efficacy of carbamazepine, gabapentin and lamotrigine for neuropathic pain in rats.Gabapentin for the treatment of carpal tunnel syndrome: a randomized controlled trial.Phantom limb pain treatment with mirtazapine: a case series.Gabapentin and pregabalin suppress tactile allodynia and potentiate spinal cord stimulation in a model of neuropathy.Pain and suffering in an adolescent with neuroblastoma.Clinical efficacy of gabapentin for paroxysmal symptoms in multiple sclerosis.Preemptive gabapentin decreases postoperative pain after lumbar discoidectomy.Niflumic acid, a TRPV1 channel modulator, ameliorates stavudine-induced neuropathic pain.Pharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate-release formulation and effect of dose escalation and food.
P2860
Q24670430-9C46C2ED-945D-49C9-AB26-8D9FF40C1627Q28344906-93F9E5B6-0100-4C94-A84A-5DE8A5ADF6F1Q34795600-B70F7737-B114-4CF2-99AC-BE00A924829FQ35045305-9909BCF8-E559-4226-A92A-F9550289F04FQ35046026-0B407845-7AAB-4FE1-9B7D-B2123E48376AQ35373677-4BCF2983-9F5A-4DB2-924B-B747E3C67E83Q35824087-C420591D-1B15-417D-B557-53134B4F26CDQ36281892-3FC67504-371E-42A4-9FD1-6D46E9F6ADFAQ36460976-40EFC308-1BCF-4181-B13F-C189EB9555C5Q36967378-023D9813-41AC-47D3-BE7B-C39A9AD199C8Q37605352-E82DD65A-233C-4449-9735-4C818F269099Q38468309-377523A7-BC06-47CE-94B2-8403138E3F64Q38727526-79637B36-9EE0-47A7-A047-DE3A763437B2Q39275566-3AC3D970-627B-4E1C-8C46-51EED90BC59AQ39342051-E1883234-8010-4AB9-936B-F4079DA1F17AQ39404448-430C526E-0AB9-434F-8B45-3D76E80C1F70Q44004519-FD79A2E8-17B5-4B05-93EC-E28B95004F36Q44899052-1468773B-B581-4289-921E-BBC50FE6D28BQ45170048-2C9833AE-6070-4F8B-BDC9-3E1F74B7CBF5Q51377193-4B9AC706-7404-4B1C-A107-B388F74B771EQ53470307-7AB276F9-1FFA-488A-AD3A-5C78354442A8
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Gabapentin use in neuropathic pain syndromes.
@ast
Gabapentin use in neuropathic pain syndromes.
@en
type
label
Gabapentin use in neuropathic pain syndromes.
@ast
Gabapentin use in neuropathic pain syndromes.
@en
prefLabel
Gabapentin use in neuropathic pain syndromes.
@ast
Gabapentin use in neuropathic pain syndromes.
@en
P1476
Gabapentin use in neuropathic pain syndromes.
@en
P2093
B Nicholson
P304
P356
10.1034/J.1600-0404.2000.0006A.X
P407
P577
2000-06-01T00:00:00Z